Ms. Tzipi Ozer-Armon, CEO of Lumenis, joined the company in May 2012. Before joining Lumenis, Ms. Ozer-Armon headed the Japanese market activities of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), a business with a turnover of more than $800M. Prior to that, Ms. Ozer-Armon served as Senior Vice President of Sales and Marketing at SanDisk (Nasdaq: SNDK), having multi-billion dollars sales’ responsibility; she also served as VP & General Manager of MSystems (Nasdaq: FLSH), and as VP of Corporate Development at Comverse (Nasdaq: CMVT). Ms. Ozer-Armon’s career also includes four years at ATKearney, a Global Management Consulting company based in London, UK. Ms. Ozer-Armon holds a BA magna cum laude in Economics from Tel Aviv University, an MBA majoring in Finance and Marketing, and she is an AMP graduate of the Harvard Business School.
Mr. Shlomi Cohen, has been appointed to CFO of Lumenis in November 2015, after serving as Lumenis’ Director of Finance and Operations for the EMEA region since June 2014. Prior to joining Lumenis and during 2011 to 2014, Mr. Cohen served as Chief Financial Officer at Emblaze (LSE: BLZ), a global group of companies with a wide range of technology, software solutions, and services. Prior thereto, from to 2008 to 2010, he served as the Corporate Controller at Emblaze and Formula Systems (NASDAQ: FORTY), and as a Senior Auditor at Price Waterhouse Coopers from 2005 to 2008. Mr. Cohen holds a bachelor’s degree in accounting and economics from Tel-Aviv University, and is a certified public accountant in Israel.
Mr. Brad Oliver joined Lumenis in 2005 as an Area Sales Manager in San Diego. In 2007, Mr. Oliver was promoted to the role of Regional Sales Manager in the Western US. Thanks to his achievements, Mr. Oliver was offered to join Lumenis APAC to establish a new direct sales office in Australia & New Zealand. , Mr. Oliver and his team significantly advanced Australia and made it one of the top revenue contributing countries for Lumenis. In 2014, Mr. Oliver returned to the US as the Vice President of sales and marketing for Lumenis America’s Aesthetic sales division, and one year later was promoted to VP & Regional President of the Americas. Prior to working with Lumenis, Mr. Oliver held many management positions with the Gallo Wine Company. Brad holds a B.Sc. degree in Communications from the University of San Diego.
Mr. Zhai Qiying, Senior Vice President & Regional President of Lumenis APAC & Japan Region joined the company in 2001. Before joining Lumenis, Mr. Qiying held senior management positions with the Coherent Medical Group in his region, and joined Lumenis with the company’s ESC/Sharplan merger. Mr. Qiying started Lumenis’ Ophthalmic business in China in 1992 and has been with Lumenis since that time responsible for Lumenis’ China/APAC region.
Mr. Roy Ramati, Senior Vice President, EMEA & Business Development, joined Lumenis in June 2012. Mr. Ramati brings to his role vast management and entrepreneurial experience. Before joining Lumenis, Mr. Ramati served as VP & GM of the Enterprise Division at SanDisk Corp. and before that as VP Operations and Manager of the Memory Cards Business at Msystems, Roy was the founder and Co-CEO of the Fantine Group, a provider of business development services in Europe and a Venture Capital Fund. Mr. Ramati also served as a management consultant at Shaldor, Israel’s top management consulting firm. Mr. Ramati holds an MBA from the London Business School, and a BA from Tel Aviv University.
Ms. Hadas Padan, Vice President, Medical Business Group, joined Lumenis in December 2013. Before joining Lumenis, Ms. Padan served as Director of Product Management and Strategic Development at the Healthcare Information Solutions division of Carestream – a ~$200m business unit within the $2.3b privately-held company in the field of medical imaging systems and IT solutions. In that role Ms. Padan managed an international group and held direct responsibility over product and business management, medical advisory board & KOL relationships, global product positioning, go-to-market strategy, oversaw R&D plans, and more. Prior to Carestream, Ms. Padan served as Director of Product Management at Kodak health’s Imaging Division. Ms. Padan holds a B.Sc. and M.Sc. degrees in Industrial Engineering (magna cum laude) from the Tel Aviv University.
Mr. Rani Hagag, Vice President, Aesthetics Business Group, joined Lumenis in 2017. Prior to joining Lumenis, Mr. Hagag co-founded and served as the CEO of Biopolymer Technologies, a biochemical company that developed, patented and commercialized a disruptive technology to transform abundant plant proteins into industrial materials. In 2015, BPT was sold to a consortium of the French Public Investment Bank and Groupe Avril, forming Evertree, a global, industrial business. Previously, Mr. Hagag spent 9 years at Comverse (NASDAQ: CMVT), where he held multiple positions in the areas of corporate strategy, business development, product management and marketing, and general, business lines management. Prior to Comverse, Mr. Hagag spent several years as a strategy management consultant. Mr. Hagag holds an LL.B. and an MBA.
Mr. Ezi Hayon, Vice President Delivery & Service, joined Lumenis in October 2014. Mr. Hayon brings over 15 years of solid business experience in the healthcare industry. Prior to joining Lumenis, he served for 7 years as Executive Director of Product Management at McKesson (NYSE: MCK), an American Healthcare company with over $120 Billion in annual revenue. At McKesson Mr. Hayon was responsible for the company’s Cardiology product line, including marketing, forecasting, product roadmap planning, and strategic projects. Before that, he served as Project Manager at GE Healthcare (NYSE: GE) in the company’s MRI division, leading and managing variety of software development projects in a multi-disciplinary environment. Mr. Hayon career in the healthcare field began at ESC, one of the key companies that later merged into forming today’s Lumenis. Mr. Hayon, who is a fully-trained military medic, holds a B.Sc. degree in Computer Science from the Haifa University in Israel; and an MS in Engineering Management from the University of Wisconsin, in Madison, US.
Ms. Karen Smith, Vice President, Regulatory Affairs & Quality, joined Lumenis in October of 2017. Immediately prior to joining Lumenis, Ms. Smith served as VP, Regulation and Operations for Cyrcadia Health – a US based startup specializing in early stage breast cancer detection devices. Previously, Ms. Smith served over 26 years at Siemens Medical Solutions in the Ultrasound Business Unit. Ms. Smith held various leadership and management positions, such as Vice President of Quality and Regulations – heading a global team, spread across several sites, and leading the global management of all RA strategy and Quality Systems activities.
Mr. Ido Warshavski, Vice President, General Counsel & Corporate Secretary, joined Lumenis in December 2014. Prior to joining Lumenis he served for a decade as the chief legal officer (most recently as Senior Vice President, General Counsel & Corporate Secretary) of Given Imaging Ltd. (NASDAQ: GIVN) – the pioneer of capsule endoscopy and a leader in the development, manufacturing and sales of medical devices in the gastrointestinal field. At Given Imaging, Mr. Warshavski had responsibility over all global legal, intellectual property and compliance activities. Prior to Given Imaging, Mr. Warshavski served for 5 years as a corporate attorney in the New York law firm Proskauer Rose LLP, working primarily in the areas of securities laws, mergers & acquisitions, venture capital, and providing general corporate law services to companies, with emphasis on the medical device field. Mr. Warshavski holds a Masters of Laws (LL.M) degree from Duke University School of Law at Durham, North Carolina, and a Bachelor’s of Laws (LL.B) degree, Magna Cum Laude, from the College of Management School of Law in Tel Aviv. He is a member of the Israeli Bar Association (1997), the New York State Bar (2000), and the Association of Corporate Counsel (2004).